Year Country Study design No. of patients Success Rate (%) LOE*
Monchik et al.[14] 2006 US Retrospective [case series] 5 100 4
Guenette et al.[22] 2013 US Retrospective [case series] 14 93 4
Hay et al.[23] 2012 US Retrospective 88 100 3
Heilo et al.[25] 2011 Norway Retrospective 66 79 3
Kim et al.[26] 2008 Korea Retrospective 27 96 3
Lim et al. [27] 2007 Korea Prospective 16 100 1b
Hay et al.[28] 2013 US Prospective 25 92 1b
Lewis et al.[39] 2002 US Prospective 14 86 1b
Table 3: Studies evaluating percutaneous ethanol treatment in recurrent lymph nodes metastases in recurrent papillary thyroid carcinoma. Note: *LOE= level of evidence.